in two multicenter studies , 325 patients with advanced squamous lung cancer were randomized to receive either no treatment v oral etoposide ( vepe-sid ) 300 mg/m2 on days 1 and 2 for 6 cycles , or the same dose of oral etoposide v the same dose of oral etoposide plus cyclophosphamide 300 mg/m2 iv on days 1 and 2 , each given for 6 cycles .
C0015133
etoposide
C0280551
etoposide